Former Peruvian President Martin Vizcarra, one of the first to receive the Chinese-made vaccine, and his wife have both been diagnosed.
The outbreak of the Chinese Communist virus continues to be a global phenomenon. Former Peruvian President Martin Vizcarra and his wife, who were the first to receive a Chinese-made vaccine, have both been diagnosed.
On April 25, Vizcarra tweeted, “Despite taking the necessary protective measures to avoid bringing the virus home, both my wife and I have tested positive.” He said, “My family has taken quarantine measures, let’s not let our guard down.”
Pese a los cuidados necesarios para evitar llevar el virus a casa, mi esposa y yo hemos dado positivo al COVID y somos sintomáticos. Mi familia está tomando las medidas de aislamiento necesarias. No bajemos la guardia.
- Martín Vizcarra (@MartinVizcarraC) April 25, 2021
Vizcarra, 58, is an engineer who describes himself as a Peruvian with democratic convictions and a commitment to the country, and will be president of Peru from 2018 to 2020. He won his seat in the recent legislative elections, but was temporarily barred from the Peruvian Congress because of a scandal last year over his use of his office to get early vaccinations from the Communist Party.
Peruvian media revealed in February that Vizcarra and 470 other people had received the Chinese national vaccine in October, before the vaccination was officially launched nationwide. The scandal led to the resignation of Peru’s health minister, foreign minister and others.
Vizcarra denies using his power to advance the vaccination and claims that his brother, his wife and he were involved in clinical trials prior to the official vaccination. He has also been accused of corruption while serving as governor from 2011 to 2014.
Last November, the Peruvian Congress removed him from the presidency through impeachment.
Peru is currently experiencing a second wave of the outbreak, with more than 1.7 million people diagnosed and 59,440 deaths so far in a country of only 33 million people.
As early as January 6, Peru entered into a framework agreement with Sinopharm to purchase 38 million doses of the vaccine, and on January 26, the General Directorate of Drug Administration (GDA) granted emergency authorization for the use of the vaccine in Peru. In March and April, another 2 million and 3 million doses, respectively, went into the fight against the epidemic.
Peru’s state-run Agencia Andina news agency reported on Feb. 25 that a 53-year-old nursing woman in Iquitos was hospitalized on March 7 after suffering an adverse reaction to the vaccine, which was administered on Feb. 12.
As of March 9, 333,000 of Peru’s 33,274,000 people had received the first dose of the national vaccine, and nearly 50,000 people had received the second dose. The Ministry of Health has not yet released data comparing before and after vaccinations, as the first vaccination has only recently begun.
The Chinese authorities are pushing for “vaccine diplomacy,” but the safety and efficacy of Chinese-made vaccines have been questioned.
The safety and efficacy of Chinese-made vaccines are in question.
Chile, a South American country with a population of about 19 million, began a vaccination program last December. It began targeted vaccinations for frontline health care workers, and in February received nearly 4 million doses of the Chinese Kexing vaccine to begin administering to the elderly and key workers.
Although 35% of the population has been vaccinated, and 90% with the China Coxin vaccine, the number of confirmed cases in Chile has been rising daily for the past two months or so, with the confirmation rate up 35%. The country now has a cumulative total of more than 2.84 million confirmed cases.
Doctors at the local intensive care unit said that even if the intensive care unit doubles again, the bed utilization rate is still full. Many of these elderly people over 70 years old who received the Coxin vaccine still ended up dying of the disease, while more young and seriously ill patients also died.
In Hong Kong, where vaccination began on February 26, 18 people have died after receiving the Coxin vaccine.
In Turkey, at least 8 million people, or more than 10 percent of the population, have been vaccinated with the Coxin vaccine since mid-January. However, the outbreak rebounded in late February and 37,303 new cases were confirmed on March 30, the highest single day since the outbreak on March 11 last year. About 4.63 million people have been diagnosed in the country.
Pakistan is currently experiencing the third wave of the outbreak, which began in early February with a vaccine produced by the Chinese Communist Party. Pakistani President Arif Alvi and Prime Minister Imran Khan both tested positive for the virus after receiving the Chinese national vaccine.
The number of confirmed cases has also increased rather than decreased in countries such as Brazil, where the Chinese vaccine is used. None of the five vaccines that have been developed by the Chinese Communist Party have been approved by the World Health Organization, and no information about the trials has been published in scientific journals. Several international experts have publicly expressed their distrust of the opaque Chinese vaccines.
On January 5, Chinese vaccine expert Tao Lina revealed on social media platforms that Chinese vaccines are “the most unsafe vaccines in the world,” with up to 73 side effects after vaccination with Chinese medicines.
On March 5, Peruvian television station “WillaxTV” made public the “Universidad Peruana Cayetano Heredia” (University of Cayetano Heredia) and China National Pharmaceuticals (SinoPharm) vaccine. The data from the clinical trial of the CCP virus vaccine, conducted by the Universidad Peruana Cayetano Heredia and SinoPharm, were released.
The trial data showed that the inactivated vaccine developed by the Wuhan Institute of Biological Products of China National Pharmaceutical Group was only 11.5% effective against the CCP virus, while the vaccine developed by the Beijing Institute of Biochemistry was 33% effective.
Recent Comments